US Patent Issued to BEIJING MABWORKS BIOTECH on March 31 for "Molecules binding PD-L1 and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,155, issued on March 31, was assigned to BEIJING MABWORKS BIOTECH Co. LTD. (Beijing).

"Molecules binding PD-L1 and uses thereof" was invented by Xuechen Zhou (Beijing), Guangzhong Lin (Beijing), Jiangmei Li (Beijing), Wenqi Hu (Beijing) and Feng Li (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a molecule, e.g., a single-domain antibody, or a heavy chain only antibody, that specifically binds human PD-L1, and its use in treating diseases such as tumors."

The patent was filed on May 25, 2023, under Application No. 18/323,645.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/n...